Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 3.44 USD 0.88%
Market Cap: 39.4m USD
Have any thoughts about
Collplant Biotechnologies Ltd?
Write Note
CLGN
/
Balance Sheet
/
Accumulated Depreciation

Collplant Biotechnologies Ltd
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Collplant Biotechnologies Ltd
Accumulated Depreciation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Accumulated Depreciation
-$6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Accumulated Depreciation
-$3.9m
CAGR 3-Years
-41%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Accumulated Depreciation
-$4.2m
CAGR 3-Years
-28%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Collplant Biotechnologies Ltd
Glance View

Market Cap
39.4m USD
Industry
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

CLGN Intrinsic Value
15.33 USD
Undervaluation 78%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Collplant Biotechnologies Ltd's Accumulated Depreciation?
Accumulated Depreciation
-6m USD

Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Accumulated Depreciation amounts to -6m USD.

What is Collplant Biotechnologies Ltd's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 1Y
-20%

Over the last year, the Accumulated Depreciation growth was -20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.